A 52-year-old man with a history of gout presents with acute left flank pain and hematuria. Non-contrast CT abdomen-pelvis shows a 12 mm radiolucent stone in the left renal pelvis with moderate hydronephrosis. Serum creatinine is 1.2 mg/dL (baseline 0.9 mg/dL), and urine pH is 5.2. Urinalysis shows uric acid crystals and hematuria (2+). Urine culture is sterile and vital signs are stable. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient has a **uric acid stone** (radiolucent on CT, history of gout, acidic urine with uric acid crystals). Uric acid stones are unique because they are **radiolucent** and **potentially dissolvable** with medical management—unlike calcium oxalate or calcium phosphate stones. ## Uric Acid Stone Management Algorithm ```mermaid flowchart TD A[Uric acid stone diagnosed]:::outcome --> B{Stone size and symptoms?}:::decision B -->|Asymptomatic, <10 mm| C[Urine alkalinization + allopurinol]:::action B -->|Symptomatic, <15 mm, no renal failure| D[Alkalinization + allopurinol + observation]:::action B -->|Large >15 mm or renal failure| E[PCNL or ESWL + medical therapy]:::action C --> F[Monitor for dissolution over 4-8 weeks]:::action D --> F F --> G{Stone resolved?}:::decision G -->|Yes| H[Continue maintenance therapy]:::action G -->|No| I[Escalate to ESWL/PCNL]:::action ``` ## Key Management Principles for Uric Acid Stones **High-Yield:** Uric acid stones are the ONLY kidney stones that can be dissolved medically. This is a unique advantage and should be exploited before resorting to invasive procedures. ### Medical Dissolution Protocol 1. **Urine alkalinization:** Target urine pH >6.5 (ideally 6.5–7.0) - Potassium citrate 20–30 mEq/day in divided doses - Sodium bicarbonate 1–2 g TID as alternative - Monitor serum electrolytes and urine pH 2. **Xanthine oxidase inhibitor:** Allopurinol 300 mg OD (or febuxostat) - Reduces uric acid production - Prevents recurrence 3. **Hydration:** Maintain urine output 2–3 L/day 4. **Dietary modification:** Reduce purine intake (meat, organ meats, certain seafood) **Key Point:** Uric acid solubility increases dramatically above pH 6.5. At pH 5.2 (this patient's level), uric acid is poorly soluble. Alkalinization can dissolve 50–80% of uric acid stones within 4–8 weeks. ### Why This Patient is Suitable for Medical Management - Stone is radiolucent (uric acid, not calcium-based) - Size 12 mm (intermediate; <15 mm is favorable for dissolution) - Mild renal impairment (Cr 1.2) but no acute kidney injury - Asymptomatic after acute episode (stable, no fever, no sepsis) - Sterile urine (no infection) **Clinical Pearl:** The presence of **gout + radiolucent stone + acidic urine + uric acid crystals** is pathognomonic for uric acid nephrolithiasis. This diagnosis mandates medical dissolution as first-line. ## When to Escalate to Invasive Intervention - Stone >15 mm - Acute kidney injury (Cr >2.0 or rising) - Fever/sepsis (obstructed infected system) - Failure of medical therapy after 8–12 weeks - Recurrent symptomatic episodes **Mnemonic: ACID-DISSOLVE** — **A**lkalinize urine, **C**itrate therapy, **I**nhibit xanthine oxidase, **D**ecrease purines; **D**issolve over weeks, **I**ncrease hydration, **S**erialize pH monitoring, **S**witch to invasive if fails, **O**bserve for complications, **L**ower recurrence, **V**erify resolution, **E**nsure maintenance.